As part of our series focussing on newly available medicines in Australia, we have added a product review of use of Esketamine nasal spray in the management of Major Depressive Disorder in adults.
This review discusses pharmacological properties, mechanism of action, drug interactions and major studies featuring Esketamine. It also provides commentary and recommendations from Professor Ian Hickie, Professor of Psychiatry and the Co-Director of Health and Policy, Brain and Mind Centre, University of Sydney.
Please login below to download this issue (PDF)